Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Vivos Therapeutics (VVOS) Preferred Dividend Payments (2020)

Vivos Therapeutics has reported Preferred Dividend Payments over the past 1 years, most recently at $1.6 million for Q4 2020.

  • Quarterly Preferred Dividend Payments changed N/A to $1.6 million in Q4 2020 from the year-ago period, while the trailing twelve-month figure was $2.3 million through Dec 2020, changed N/A year-over-year, with the annual reading at $2.3 million for FY2020, 133.3% up from the prior year.
  • Preferred Dividend Payments was $1.6 million for Q4 2020 at Vivos Therapeutics, up from $250000.0 in the prior quarter.
  • Over five years, Preferred Dividend Payments peaked at $1.6 million in Q4 2020 and troughed at $250000.0 in Q1 2020.